Lasa Supergenerics
LASA · Pharma > Pharmaceuticals & Drugs · Chairman: Omkar Herlekar · MD: Omkar Herlekar · Listing date: Sept. 22, 2017 · Employees: 194 · Mumbai · http://lasalabs.com

Stock Price vs Company Growth
1d
2.1%
1w
7.0%
1m
16.3%
3m
8.8%
6m
24.5%
1y
4.8%
5y
10.5%
all
20.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 28.9 2.1%
23.3
30.7
Company Overview

Sales
120 Cr
Growth: -7.5%
Profit after Tax
-22.7 Cr
Growth: 16.4%
Micro Cap
145 Cr
P/S: 1.2x
Industry P/S: 3.3x
Fundamentals

Sales (Cr) ₹ 120
Growth -7.5%
EBITDA -0.3%
P/S 1.2x
Dividend 0.0%
P/E -6.4x
Book Value ₹ 18.3
PEG Ratio 0.8x
ROE -22.9%
P/B 1.6x
Shareholding Pattern

Institutions
Promoters
Omkar Pravin Herlekar
64.47 %
Others
Bebi Dharma Padhir
2.82 %
Anil Vishanji Dedhia
1.76 %
Increase    Decrease    No change
Company Profile Detailed

The company is specialises in ‘catalyst chemistry’ and manufactures anthelmintic/ veterinary API products with the largest production capabilities and product categories in IndiaProduct CategoriesVeterinary API ProductsOther API ProductsAnimal Feed IngredientsReagents For Therapeutic Use
Investors (18)
Followers (3)